CJC-1295 Purported Benefits: Increased muscle mass Fat loss Enhanced recovery Anti-aging effects Potential Risks and Complications: Hormonal Imbalances: Overstimulating growth hormone can lead to conditions like acromegaly, diabetes, and thyroid dysfunction
However, it is not FDA-approved for medical treatment or injection, and regulatory status may vary by use
Yatmaz S, Seow HJ, Gualano RC, et al
The GST-fusion protein first binds to glutathione agarose, and then after other contaminating proteins have been washed away, reduced glutathione is added to elute the GST-fusion protein from the resin (Figure 5)
17.5% prior to treatment
Regulatory status As of June 2026, tesamorelin is FDA-approved only for HIV-associated lipodystrophy (EGRIFTA WR / EGRIFTA SV)